🚀 VC round data is live in beta, check it out!
Median Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Median Technologies and similar public comparables like SANUWAVE Health, CVRx, Humacyte, OraSure and more.
Median Technologies Overview
About Median Technologies
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
Founded
2002
HQ
Employees
164
Website
Financials (LTM)
EV
$245M
Median Technologies Financials
Median Technologies reported last 12-month revenue of $30M and negative EBITDA of ($18M).
In the same LTM period, Median Technologies generated ($18M) in EBITDA losses and had net loss of ($22M).
Revenue (LTM)
Median Technologies P&L
In the most recent fiscal year, Median Technologies reported revenue of $26M and EBITDA of ($22M).
Median Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $30M | XXX | $26M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $28M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 104% | XXX | XXX | XXX |
| EBITDA | ($18M) | XXX | ($22M) | XXX | XXX | XXX |
| EBITDA Margin | (59%) | XXX | (84%) | XXX | XXX | XXX |
| EBIT Margin | (67%) | XXX | (97%) | XXX | XXX | XXX |
| Net Profit | ($22M) | XXX | ($29M) | XXX | XXX | XXX |
| Net Margin | (75%) | XXX | (108%) | XXX | XXX | XXX |
| Net Debt | — | — | $23M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Median Technologies Stock Performance
Median Technologies has current market cap of $212M, and enterprise value of $245M.
Market Cap Evolution
Median Technologies' stock price is $5.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $245M | $212M | 0.3% | XXX | XXX | XXX | $-0.78 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedian Technologies Valuation Multiples
Median Technologies trades at 8.3x EV/Revenue multiple, and (13.9x) EV/EBITDA.
EV / Revenue (LTM)
Median Technologies Financial Valuation Multiples
As of April 8, 2026, Median Technologies has market cap of $212M and EV of $245M.
Equity research analysts estimate Median Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Median Technologies has a P/E ratio of (9.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $212M | XXX | $212M | XXX | XXX | XXX |
| EV (current) | $245M | XXX | $245M | XXX | XXX | XXX |
| EV/Revenue | 8.3x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBITDA | (13.9x) | XXX | (11.0x) | XXX | XXX | XXX |
| EV/EBIT | (12.4x) | XXX | (9.6x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 8.9x | XXX | XXX | XXX |
| P/E | (9.6x) | XXX | (7.4x) | XXX | XXX | XXX |
| EV/FCF | (13.9x) | XXX | (11.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Median Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Median Technologies Margins & Growth Rates
Median Technologies' revenue in the last 12 month grew by 36%.
Median Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Median Technologies' rule of 40 is (1%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Median Technologies' rule of X is 52% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Median Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 36% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | (59%) | XXX | (84%) | XXX | XXX | XXX |
| EBITDA Growth | (36%) | XXX | (14%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (1%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 52% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 201% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Median Technologies Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SANUWAVE Health | XXX | XXX | XXX | XXX | XXX | XXX |
| CVRx | XXX | XXX | XXX | XXX | XXX | XXX |
| Humacyte | XXX | XXX | XXX | XXX | XXX | XXX |
| OraSure | XXX | XXX | XXX | XXX | XXX | XXX |
| Anika Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Median Technologies M&A Activity
Median Technologies acquired XXX companies to date.
Last acquisition by Median Technologies was on XXXXXXXX, XXXXX. Median Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Median Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedian Technologies Investment Activity
Median Technologies invested in XXX companies to date.
Median Technologies made its latest investment on XXXXXXXX, XXXXX. Median Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Median Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Median Technologies
| When was Median Technologies founded? | Median Technologies was founded in 2002. |
| Where is Median Technologies headquartered? | Median Technologies is headquartered in France. |
| How many employees does Median Technologies have? | As of today, Median Technologies has over 164 employees. |
| Is Median Technologies publicly listed? | Yes, Median Technologies is a public company listed on Euronext Paris. |
| What is the stock symbol of Median Technologies? | Median Technologies trades under ALMDT ticker. |
| When did Median Technologies go public? | Median Technologies went public in 2011. |
| Who are competitors of Median Technologies? | Median Technologies main competitors are SANUWAVE Health, CVRx, Humacyte, OraSure. |
| What is the current market cap of Median Technologies? | Median Technologies' current market cap is $212M. |
| What is the current revenue of Median Technologies? | Median Technologies' last 12 months revenue is $30M. |
| What is the current revenue growth of Median Technologies? | Median Technologies revenue growth (NTM/LTM) is 36%. |
| What is the current EV/Revenue multiple of Median Technologies? | Current revenue multiple of Median Technologies is 8.3x. |
| Is Median Technologies profitable? | No, Median Technologies is not profitable. |
| What is the current EBITDA of Median Technologies? | Median Technologies has negative EBITDA and is not profitable. |
| What is Median Technologies' EBITDA margin? | Median Technologies' last 12 months EBITDA margin is (59%). |
| What is the current EV/EBITDA multiple of Median Technologies? | Current EBITDA multiple of Median Technologies is (13.9x). |
| What is the current FCF of Median Technologies? | Median Technologies' last 12 months FCF is ($18M). |
| What is Median Technologies' FCF margin? | Median Technologies' last 12 months FCF margin is (59%). |
| What is the current EV/FCF multiple of Median Technologies? | Current FCF multiple of Median Technologies is (13.9x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.